INTRODUCTION
Glucosylceramide /J-glucosidase (EC 3.2.1.45) is a membranebound lysosomal hydrolase that participates in the degradation of glycosphingolipids by cleaving glucocerebroside to yield glucose and ceramide. A deficiency of this enzymic activity results in Gaucher disease, a lysosomal storage disorder characterized by the accumulation of glucocerebroside [1] .
Acidic lipids have been shown to be potent activators of purified ,-glucosidase from liver, spleen and brain. One of the most effective physiological lipid activators is the acidic phospholipid, phosphatidylserine (PtdSer) [2] . In addition to the acidic lipids, mammalian tissues contain a low-molecular-mass protein which acts synergistically with acidic lipids to activate fi-glucosidase [3, 4] . This protein, saposin C, has been shown to have a positive effect on /-glucosidase activity in the absence of lipid [5] , but the highest activities are obtained when saposin C and an acidic lipid are both present in the assay [5, 6] .
In general, 8-glucosidase activity increases with increasing concentration of the activator lipid. In the presence of saposin C, less acidic lipid is needed to stimulate the enzyme maximally [5, 6] . The physiological relevance of saposin C activation of glucosylceramide ,-glucosidase is evident by the identification of patients with a form of Gaucher disease caused by a deficiency of saposin C [7] .
Activation by acidic lipids and saposin C is a result of an increase in the enzyme's Vmax as well as a decrease in Km [6, 8] . Kinetic analyses indicate that glucosylceramide ,J-glucosidase has two activator-binding sites: one that affects the maximum rate of the reaction, and another that affects the enzyme's affinity for substrate [9] . In another study, the binding sites for saposin C and PtdSer were shown to be distinct [5] .
The effects of acidic lipids and saposin C have been shown to be due to direct interaction with the enzyme, and not to direct interactions with each other or with the substrate [5, 6] . However, saposin C clearly affects the interaction of acidic lipids with the enzyme. Saposin C has been shown to increase binding of PtdSer to ,J-glucosidase, probably by affecting the enzyme's conformation [5] .
alone; this was due to both an increase in Vmax and a decrease in Km. In contrast, at PtdSer concentrations greater than 100 ,uM, Ca2l inhibited ,-glucosidase activity by 50%, due to a 2-fold increase in Km. Ca2+ was inhibitory at all PtdSer concentrations tested when both PtdSer and saposin C were present in the assay. Ca2+ ions were also shown to cause changes in the aggregation states of PtdSer. These results suggest that changes in Ca2+ concentration may play a role in regulating ,-glucosidase activity in vivo, thereby modulating sphingolipid metabolism. The implications of these findings are discussed.
The fact that specific lipids and saposin C alter /I-glucosidase activity in vitro suggests that this enzyme is regulated similarly in vivo, as well. Glucosylceramide ,B-glucosidase resides in the lysosomal membrane, surrounded by other membrane proteins and multiple species of lipids. Saposin C is also a lysosomal protein [10] , present in the lumen of the organelle. Although much is known about the kinetic effects of f-glucosidase activation, little is known about the regulation of activation. For example, it is not known how saposin C, which is soluble, comes in contact with ,-glucosidase, which is membrane-bound.
In theory, the regulation of,-glucosidase activity in the lysosome could be accomplished by changes in the local concentrations oflysosomal membrane lipids or saposin C, or alterations in the interaction between the enzyme and its activators. The elucidation of such regulatory mechanisms is important for understanding the pathogenesis of the different clinical forms of Gaucher disease and for developing maximally effective therapies. Additionally, it has been shown that ceramide, a product of the fi-glucosidase reaction, affects multiple cellular functions such as growth, differentiation and viability [11] . Thus studies on the regulation of ,-glucosidase activity potentially have a still broader significance.
In the present report, the effects of Ca2+ ions on PtdSer-and saposin C-stimulated /J-glucosidase activity were investigated. Ca2+ is a known regulator of various intracellular events, and has been shown to interact directly with PtdSer [12] to regulate the activity of other enzymes that bind PtdSer [13] [14] [15] . We found that Ca2+ affects PtdSer-and saposin C-stimulated fl-glucosidase activity in both positive and negative ways, depending on the concentration of the phospholipid and the presence or absence of saposin C. Purffication of rat liver glucosylceramide f8-glucosidase Frozen rat livers were thawed, minced, and processed through the sodium cholate, ammonium sulphate, and butan-l-ol extraction steps as described by Furbish et al. [16] . The resulting preparation (purified 9-fold) was dialysed against 0.1 M sodium acetate, pH 6.0, containing 5 mM EDTA and 1 mM 2-mercaptoethanol (buffer A).
EXPERIMENTAL
The dialysed preparation was subjected to octyl-Sepharose chromatography. 8-Glucosidase was eluted with 0.5 M NaSCN and 60 % ethylene glycol in buffer A. The resulting preparation (purified 480-fold) was dialysed against 10% ethylene glycol in 0.1 M sodium acetate, pH 6.0, 5 mM EDTA and 1 mM 2-mercaptoethanol (buffer B).
The dialysed octyl-Sepharose pool was then subjected to phenyl-Sepharose chromatography. /?-Glucosidase was eluted with 0.5 M NaSCN and 60% ethylene glycol in buffer A.
Fractions containing fl-glucosidase activity were pooled (1800-fold purification) and dialysed against buffer B.
Finally, an affinity column of immobilized PtdSer and saposin C in polyacrylamide, made by a modification of the method of Uchida and Filburn [17] , was employed. The enzyme was eluted with 0.5 M NaSCN and 60 % ethylene glycol in buffer A. The /3-glucosidase-containing fractions were pooled and dialysed against 90 % ethylene glycol in 10 mM sodium acetate, pH 6.0, and 1 mM 2-mercaptoethanol. The dialysed enzyme preparation was stored at -30 'C. This protocol resulted in a final purification of 22000-fold. Samples were diluted 2-fold with distilled deionized water immediately before use in this study.
fi-Glucosidase assay
Glucosylceramide ,-glucosidase activity was determined with MUGlc as substrate. The standard assay contained 5 mM MUGlc, 0.2 M sodium acetate, pH 5.5, and the indicated amounts of PtdSer and CaCl2, in a final volume of 0.1 ml. The incubation was carried out for 30 min at 37 'C, and fluorescence was determined as described elsewhere [6] . All assays were performed in duplicate. One unit of,-glucosidase activity is the amount ofenzyme that releases 1 nmol ofglucose from MUGlc/h at 37 'C.
In this paper, ,-glucosidase activity refers to glucosylceramide ,3-glucosidase acting on the water-soluble substrate, MUGlc. Use of this non-physiological substrate is necessary when studying lipid effects on glucosylceramide ,-glucosidase because the natural substrate is insoluble in the absence of lipids or detergents. In studies in which the effects of a lipid on enzyme activity are examined, it is essential to avoid interference from other lipids or detergents that are usually added to the /-glucosidase assay mixture [6] . Therefore, detergents and lipids other than PtdSer were not included in the assay mixture in this study.
Addition of 0.25 mM conduritol B-epoxide (CBE), a specific active-site inhibitor of glucosylceramide /-glucosidase [18] , to the assay medium resulted in greater than 95 % inhibition of the ,3-glucosidase activity of the purified enzyme preparation. Therefore, the activity measured in this study is due to glucosylceramide /3-glucosidase, and not some other ,6-glucosidase.
Preparafton of saposin C Saposin C was purified from human Type 1 Gaucher-disease spleen as previously described [4] . In the present paper, one unit of saposin C activity is defined as the amount of saposin C required to stimulate /-glucosidase activity 2-fold in the presence of 13 ,uM PtdSer. The preparation of saposin C used in this study had a specific activity of 2778 units/mg.
Determinatlon of kinetic parameters, Km and V,L /3-Glucosidase determinations were performed at ten different MUGlc concentrations covering a 20-fold range as described by Segel [19] . K. and Vmax values were determined by fitting the data to a rectangular hyperbola with a computer-analysis method described by Cleland [20] .
Preparation of aqueous solutions of PtdSer
A chloroform/methanol (2: 1, v/v) solution of PtdSer was dried under nitrogen gas, and the residue was suspended in water and sonicated for 1 min at 4°C, with the standard microtip on a Heat-Systems Ultrasonics cell disruptor. The phosphorus content of the phospholipid suspension was determined by the method of Bartlett [21] , with potassium phosphate as standard.
Examination of aggregafton states of PtdSer
The aggregation of PtdSer at different concentrations was examined with the fluorescent dye N-phenyl-1-naphthylamine as described by Kovatchev et al. [22] Aggregation studies were carried out at 37°C in 0.2 M sodium acetate buffer, pH 5.5.
Protein determination
The protein concentration of,3-glucosidase preparations was estimated by the method of Bradford [23] , with BSA as standard.
RESULTS
Effect of Ca2+ concentration on /I-glucosidase activity Ca2+ ions can interact directly with acidic phospholipids, thereby either enhancing or disrupting protein-lipid interactions. Thus we were interested in determining whether Ca2+ affects PtdSerenhanced ,-glucosidase activity. As shown in Figure 1 , Ca2+ did alter this activity; the effects depended on the concentration of PtdSer and, to a lesser extent, the concentration of Ca2+ in the assay medium. At a low PtdSer concentration (3 1M), Ca2+ had no effect on /8-glucosidase activity. However, at a phospholipid concentration of 13 ,uM, Ca2+ stimulated ,3-glucosidase activity greater than 2-fold, and the stimulation was maximal at 5 mM Ca2+. In contrast, Ca2+ inhibited ,-glucosidase activity by 50 % in the presence of 380 uM PtdSer. No effect of Ca2+ on ,-glucosidase activity was detected in the absence of PtdSer (results not shown). Also, the activation and inhibition were due to the cation and not to Cl-, since 1-10 mM NaCl had no effect on ,8- Effect of Ca2+ on saposin C activation of f8-glucosidase all PtdSer concentrations tested. When Ca2+ was included in the /J-glucosidase assay mixture with saposin C and PtdSer, the stimulatory effect of saposin C was abolished (Table 1) at both low (13 ,uM) and high (380 ,uM) PtdSer concentrations.
Evaluation of the kinetic basis for Ca2+ effects
In order to study the basis of the observed activation and inhibition of ,-glucosidase activity by Ca2 , the effects of Ca2+ on the kinetic parameters of fi-glucosidase were examined ( Figure 2 intersect), no effect on either of the kinetic parameters was observed.
Additionally, in the presence of 380 ,uM PtdSer, Ca2+ caused a 2-fold increase in the Km (from 2.0 to 4.2 mM), but had no effect on the Vmax, indicating that the inhibition by Ca2+ observed in Figure 2 was due to a decreased affinity of the enzyme for the substrate. When saposin C was included in the assay medium, the effects of Ca2+ on the kinetic parameters were different (Table 3 ). In the absence of PtdSer, there was no effect of Ca2+ on the kinetic parameters measured in the presence of saposin C. When 13 #M PtdSer and saposin C were present, the addition of Ca2+ caused a decrease in the Vm.ax from 464 to 80 units/,ug of protein. Ca2+ also caused a decrease in the Vmax when 380 1sM PtdSer and saposin C were used (660 versus 144 units/,ug). This is in contrast with the results obtained with 380 ,uM PtdSer alone, where the Ca 2+ inhibition was due to a change in the Km.
Effect of Ca2+ Ions on the aggregation state of PtdSer
The kinetic experiments demonstrated that the effects of Ca 2+ on PtdSer-stimulated /8-glucosidase activity were dependent on the concentration of PtdSer used in the assay. We were therefore interested in determining whether Ca2+ affected the aggregation of PtdSer at different PtdSer concentrations.
The fluorescent dye N-phenyl-l-naphthylamine can be used to monitor changes in the aggregation state of a lipid, and is used in determining the critical micellar concentrations of lipids [22] . The inhibitory effects of Ca2+ on ,-glucosidase activity in the presence of saposin C are more complicated; they can be explained by effects on PtdSer aggregation and effects on the saposin. Saposin C has been shown to bind to ,-glucosidase, but not to PtdSer or the substrate [5, 6] . However, in the presence of saposin C lower concentrations of PtdSer are required for activation, indicating that saposin C affects the binding of PtdSer aggregates to the enzyme. It is possible that a very low concentration of Ca2+ is present endogenously in the saposin C preparation, and may contribute to the stimulatory effect of the saposin on ,-glucosidase activity.
The change in the aggregation state of PtdSer that occurs in the presence of 5 mM Ca2+ may create forms of the lipid that are not optimal for binding to the enzyme-saposin C complex. If that is the case, negative effects on fl-glucosidase activity, such as those presented in Tables 1 and 3 , would be expected in the presence of Ca2 .
The inhibitory effects of Ca2+ on PtdSer-and saposin Cstimulated f8-glucosidase activity might also be due to an effect on the binding of the saposin to the enzyme. However, this is unlikely since Ca2+ did not affect the ability of saposin to lower Km in the absence of PtdSer (compare Tables 2 and 3) . One possible mechanism for the intracellular modulation of ,-glucosidase activity by Ca2+ is alterations in Ca2+ concentrations at the lysosomal membrane or inside the lysosome. In the context of /3-glucosidase located in a lysosomal membrane, Ca2+ could facilitate the interaction between ,-glucosidase and nearby PtdSer molecules that are also a part of the membrane. Alternatively, Ca2+ could affect saposin C-mediated enhancement of lysosomal ,-glucosidase activity by modulating saposin and/or PtdSer binding.
Regulation of ,-glucosidase activity is especially important to understand, in view of the current use of enzyme replacement therapy for the treatment of Gaucher disease [24] . In order to achieve maximal therapeutic advantage, aspects of the enzyme's regulation in vivo should be taken into consideration. It has been noted that saposin C levels increase in tissues of persons with Gaucher disease [4] , indicating that synthesis of the activator protein is regulated by the concentration of glucocerebroside and/or the level of ,-glucosidase, and is a point of regulation for fl-glucosidase activity. It has also been shown that minimal changes in intralysosomal pH can alter ,J-glucosidase activity, and that different Gaucher-disease genotypes are affected differentially by variations in pH [25] .
Regulated breakdown of glucosylceramide could also be physiologically relevant as a means ofcontrolling the intracellular levels of various sphingolipid metabolites that, in turn, affect critical processes required for normal cell function and growth. Sphingosine and lysosphingolipids have been shown to be potent inhibitors of protein kinase C [26] , and are thought to be involved in the regulation of that enzyme in vivo [27] . Ceramide, a product of the ,8-glucosidase reaction, has been shown to affect many different cell functions, including growth and differentiation, and has been shown to be cytotoxic in some circumstances [1 1] .
Also, accumulation of lysosphingolipids, and the resulting inhibition of protein kinase C, in neural tissue ofpersons afflicted with sphingolipid storage diseases is believed to be responsible for the extensive neurological dysfunction noted in some of those diseases [26] . The skeletal pathology associated with Gaucher disease might also be due to the effects of accumulated glucocerebroside and/or glucosylsphingosine in skeletal tissues.
Continued investigation into the regulation of /8-glucosidase activity within the lysosome and the role of sphingolipids in cellular physiology is essential to provide information necessary for the further development of therapies for Gaucher disease and other sphingolipidoses. This study suggests that Ca2+ plays a role in the regulation of fl-glucosidase activity and, consequently, plays a role in sphingolipid metabolism that can have wideranging effects on cells. 
